← Back to Search

Behavioral Intervention

Behavioral Interventions for Type 2 Diabetes (COMMITTED2-KC Trial)

N/A

Recruiting

Led By Jared Bruce, PhD

Research Sponsored by University of Missouri, Kansas City

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 to 65

Currently receiving treatment for diabetes by a licensed healthcare provider

Must not have

Diagnosis of a medical/psychiatric condition that would prevent participation in the study

Secondary type 2 diabetes

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 14 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a program that combines diabetes coaching, financial rewards, and continuous glucose monitoring to see if it can help adults with type 2 diabetes better manage their condition. The study aims to determine

Who is the study for?

Adults with type 2 diabetes in Kansas City who are interested in improving their blood sugar management may qualify for this study. Participants should be willing to follow a diabetes treatment plan, use continuous glucose monitoring, and engage with coaching sessions.

What is being tested?

The trial is testing a program that combines continuous glucose monitoring with personalized coaching and financial incentives to see if it helps patients better stick to their diabetes treatment plans and manage their blood sugar levels.

What are the potential side effects?

Since the intervention involves behavioral changes rather than medication, side effects are minimal but could include potential stress or anxiety from lifestyle adjustments and the pressure of adhering to the treatment plan.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Select...

I am currently being treated for diabetes by a healthcare professional.

Select...

I have been diagnosed with type 2 diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have any health or mental conditions that would stop me from joining the study.

Select...

I have type 2 diabetes.

Select...

I use short-acting insulin for my diabetes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 14 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 14 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 14 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Hemoglobin A1C

Time in target blood glucose range per CGM

Secondary study objectives

Diabetes Distress Scale

Diabetes Quality of Life Brief Inventory

Motivation and Confidence Ruler

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Behavioral Intervention with financial rewards and coachingExperimental Treatment1 Intervention

Individuals in the treatment group will receive financial rewards (contingency management) and diabetes coaching (motivational interviewing) in addition to wearing a continuous glucose monitor while receiving their usual diabetes treatment.

Group II: ControlActive Control1 Intervention

Individuals in the control group will not receive any interventions and will only wear a continuous glucose monitor while receiving their usual diabetes treatment.

0 / 6Eligibility criteria met